The scientist’s investigation covers issues in Internal medicine, Leukemia, Myeloid leukemia, Chemotherapy and Oncology. His Internal medicine study combines topics in areas such as Gastroenterology and Surgery. His work carried out in the field of Leukemia brings together such families of science as Myeloid, Cytogenetics, Transplantation and Pathology.
As a part of the same scientific study, William G. Woods usually deals with the Myeloid leukemia, concentrating on Pediatrics and frequently concerns with Epidemiology, Cohort study, Mass screening, Screening for Neuroblastoma and Neuroblastoma. In his study, which falls under the umbrella issue of Chemotherapy, Chemotherapy regimen, Immunophenotyping and Subsequent Relapse is strongly linked to White blood cell. His work deals with themes such as Cancer, Cancer research, Gene rearrangement, Chromosomal translocation and Cytarabine, which intersect with Oncology.
William G. Woods mostly deals with Internal medicine, Oncology, Leukemia, Myeloid leukemia and Chemotherapy. The study incorporates disciplines such as Gastroenterology and Surgery in addition to Internal medicine. William G. Woods has researched Oncology in several fields, including Hematopoietic stem cell transplantation, Clinical trial, Survival analysis and Cohort.
His research in Leukemia intersects with topics in Myeloid and Survival rate. The various areas that he examines in his Chemotherapy study include Regimen and Randomized controlled trial. William G. Woods interconnects Pediatrics and Pathology in the investigation of issues within Cancer.
William G. Woods focuses on Internal medicine, Oncology, Myeloid leukemia, Chemotherapy and Cohort. His study in Leukemia, Disease, Transplantation, Retrospective cohort study and Incidence are all subfields of Internal medicine. His Leukemia research includes elements of Myeloid and Surrogate endpoint.
His study in Oncology is interdisciplinary in nature, drawing from both Hematopoietic stem cell transplantation, Clinical trial and Minimal residual disease. William G. Woods has included themes like Down syndrome, Cancer, Pediatrics and Induction chemotherapy in his Myeloid leukemia study. His research on Chemotherapy focuses in particular on Cytarabine.
William G. Woods mainly focuses on Internal medicine, Oncology, Myeloid leukemia, Chemotherapy and Childhood AML. Leukemia and Disease are among the areas of Internal medicine where William G. Woods concentrates his study. His Leukemia research integrates issues from Young adult, Sarcoma and Survival rate.
His Oncology research is multidisciplinary, relying on both Solid tumor, Cerebrospinal fluid, Fms-Like Tyrosine Kinase 3, Myeloid and Myeloid leukaemia. His studies deal with areas such as Retrospective cohort study, Down syndrome, Pediatrics and Cohort as well as Myeloid leukemia. His Chemotherapy research is multidisciplinary, incorporating elements of Hematopoietic stem cell transplantation and Transplantation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia
Soheil Meshinchi;William G. Woods;Derek L. Stirewalt;David A. Sweetser.
A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission: a report from the Children's Cancer Group
William G. Woods;Steven Neudorf;Stuart Gold;Jean Sanders.
Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: a report from the Children's Cancer Group
William G. Woods;Nathan Kobrinsky;Jonathan D. Buckley;Jae Won Lee.
Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia.
John H. Kersey;Daniel Weisdorf;Mark E. Nesbit;Tucker W. LeBien.
The New England Journal of Medicine (1987)
SCREENING OF INFANTS AND MORTALITY DUE TO NEUROBLASTOMA
William G. Woods;Ru-Nie Gao;Jonathan J. Shuster;Leslie L. Robison.
The New England Journal of Medicine (2002)
Distinctive Demography, Biology, and Outcome of Acute Myeloid Leukemia and Myelodysplastic Syndrome in Children With Down Syndrome: Children's Cancer Group Studies 2861 and 2891
Beverly J. Lange;Nathan Kobrinsky;Dorothy R. Barnard;Diane C. Arthur.
Pleuropulmonary blastoma the so-called pulmonary blastoma of childhood
J. Carlos Manivel;John R. Priest;Jan Watterson;Marie E Steiner.
A Randomized Study of the Prevention of Acute Graft-versus-Host Disease
Norma K. C. Ramsay;John H. Kersey;Leslie L. Robison;Philip B. McGlave.
The New England Journal of Medicine (1982)
Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group.
Joanne M. Hilden;Patricia A. Dinndorf;Sharon O. Meerbaum;Harland Sather.
Occupational exposures of parents of children with acute nonlymphocytic leukemia: a report from the Childrens Cancer Study Group.
Buckley Jd;Robison Ll;Swotinsky R;Garabrant Dh.
Cancer Research (1989)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: